Quality by design

Screening of critical variables and formulation optimization of Eudragit e nanoparticles containing dutasteride

Se Jin Park, Gwang Ho Choo, Sung Joo Hwang, Min Soo Kim

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The study was aimed at screening, understanding, and optimizing product variability of dutasteride-loaded Eudragit E nanoparticles prepared by solvent displacement using Plackett-Burman screening and a central composite design. The independent process and formulation factors selected included: drug loading (%), solute concentration (mg/mL), Soluplus concentration (mg/mL), injection rate (mL/min), organic solvent type (methanol or ethanol), stirring rate (rpm), and organic-to-aqueous phase volume ratio. Among these factors, solute concentration was associated with increased particle size, broad particle size distribution, and enhanced entrapment efficiency. On the other hand, Soluplus concentration played a role in decreasing particle size, narrowing particle size distribution, and reducing entrapment efficiency. Other formulation and process factors did not have a significant impact on nanoparticle properties, assuming they were within the limits used in this study. The optimized formulation was achieved with 20 mg/mL solute and 3.22 mg/mL Soluplus, and the observed responses were very close to the values predicted using the response surface methodology. The results clearly showed that quality by design concept could be effectively applied to optimize dutasteride-loaded Eudragit E nanoparticles.

Original languageEnglish
Pages (from-to)593-601
Number of pages9
JournalArchives of pharmacal research
Volume36
Issue number5
DOIs
Publication statusPublished - 2013 May 1

Fingerprint

Particle Size
Nanoparticles
Screening
Particle size analysis
Particle size
Organic solvents
Methanol
Ethanol
Composite materials
Pharmaceutical Preparations
Injections
Dutasteride
polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer
methylmethacrylate-methacrylic acid copolymer
Eudragit-E

All Science Journal Classification (ASJC) codes

  • Drug Discovery
  • Molecular Medicine
  • Organic Chemistry

Cite this

@article{ba4970da25344fb98057fb3f14b52888,
title = "Quality by design: Screening of critical variables and formulation optimization of Eudragit e nanoparticles containing dutasteride",
abstract = "The study was aimed at screening, understanding, and optimizing product variability of dutasteride-loaded Eudragit E nanoparticles prepared by solvent displacement using Plackett-Burman screening and a central composite design. The independent process and formulation factors selected included: drug loading ({\%}), solute concentration (mg/mL), Soluplus concentration (mg/mL), injection rate (mL/min), organic solvent type (methanol or ethanol), stirring rate (rpm), and organic-to-aqueous phase volume ratio. Among these factors, solute concentration was associated with increased particle size, broad particle size distribution, and enhanced entrapment efficiency. On the other hand, Soluplus concentration played a role in decreasing particle size, narrowing particle size distribution, and reducing entrapment efficiency. Other formulation and process factors did not have a significant impact on nanoparticle properties, assuming they were within the limits used in this study. The optimized formulation was achieved with 20 mg/mL solute and 3.22 mg/mL Soluplus, and the observed responses were very close to the values predicted using the response surface methodology. The results clearly showed that quality by design concept could be effectively applied to optimize dutasteride-loaded Eudragit E nanoparticles.",
author = "Park, {Se Jin} and Choo, {Gwang Ho} and Hwang, {Sung Joo} and Kim, {Min Soo}",
year = "2013",
month = "5",
day = "1",
doi = "10.1007/s12272-013-0064-z",
language = "English",
volume = "36",
pages = "593--601",
journal = "Archives of Pharmacal Research",
issn = "0253-6269",
publisher = "Pharmaceutical Society of Korea",
number = "5",

}

Quality by design : Screening of critical variables and formulation optimization of Eudragit e nanoparticles containing dutasteride. / Park, Se Jin; Choo, Gwang Ho; Hwang, Sung Joo; Kim, Min Soo.

In: Archives of pharmacal research, Vol. 36, No. 5, 01.05.2013, p. 593-601.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Quality by design

T2 - Screening of critical variables and formulation optimization of Eudragit e nanoparticles containing dutasteride

AU - Park, Se Jin

AU - Choo, Gwang Ho

AU - Hwang, Sung Joo

AU - Kim, Min Soo

PY - 2013/5/1

Y1 - 2013/5/1

N2 - The study was aimed at screening, understanding, and optimizing product variability of dutasteride-loaded Eudragit E nanoparticles prepared by solvent displacement using Plackett-Burman screening and a central composite design. The independent process and formulation factors selected included: drug loading (%), solute concentration (mg/mL), Soluplus concentration (mg/mL), injection rate (mL/min), organic solvent type (methanol or ethanol), stirring rate (rpm), and organic-to-aqueous phase volume ratio. Among these factors, solute concentration was associated with increased particle size, broad particle size distribution, and enhanced entrapment efficiency. On the other hand, Soluplus concentration played a role in decreasing particle size, narrowing particle size distribution, and reducing entrapment efficiency. Other formulation and process factors did not have a significant impact on nanoparticle properties, assuming they were within the limits used in this study. The optimized formulation was achieved with 20 mg/mL solute and 3.22 mg/mL Soluplus, and the observed responses were very close to the values predicted using the response surface methodology. The results clearly showed that quality by design concept could be effectively applied to optimize dutasteride-loaded Eudragit E nanoparticles.

AB - The study was aimed at screening, understanding, and optimizing product variability of dutasteride-loaded Eudragit E nanoparticles prepared by solvent displacement using Plackett-Burman screening and a central composite design. The independent process and formulation factors selected included: drug loading (%), solute concentration (mg/mL), Soluplus concentration (mg/mL), injection rate (mL/min), organic solvent type (methanol or ethanol), stirring rate (rpm), and organic-to-aqueous phase volume ratio. Among these factors, solute concentration was associated with increased particle size, broad particle size distribution, and enhanced entrapment efficiency. On the other hand, Soluplus concentration played a role in decreasing particle size, narrowing particle size distribution, and reducing entrapment efficiency. Other formulation and process factors did not have a significant impact on nanoparticle properties, assuming they were within the limits used in this study. The optimized formulation was achieved with 20 mg/mL solute and 3.22 mg/mL Soluplus, and the observed responses were very close to the values predicted using the response surface methodology. The results clearly showed that quality by design concept could be effectively applied to optimize dutasteride-loaded Eudragit E nanoparticles.

UR - http://www.scopus.com/inward/record.url?scp=84878258812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878258812&partnerID=8YFLogxK

U2 - 10.1007/s12272-013-0064-z

DO - 10.1007/s12272-013-0064-z

M3 - Article

VL - 36

SP - 593

EP - 601

JO - Archives of Pharmacal Research

JF - Archives of Pharmacal Research

SN - 0253-6269

IS - 5

ER -